Antibodies aggravate the development of ischemic heart failure

Keppner, Lea; Heinrichs, Margarete; Rieckmann, Max; Jocelyne, Demengeot; Frantz, Stefan; Hofmann, Ulrich; Ramos, Gustavo

http://hdl.handle.net/10400.7/948

Use this identifier to reference this record.

Name:	Description:	Size:	Format:
Keppner.pdf		1.27 MB	Adobe PDF	Download

Send Feedback

Authors

Abstract(s)

Heart-specific antibodies have been widely associated with myocardial infarction (MI). However, it remains unclear whether autoantibodies mediate disease progression or are a byproduct of cardiac injury. To disambiguate the role of immunoglobulins in MI, we characterized the development of ischemic heart failure in agammaglobulinemic mice (AID-/-μS-/-). Although these animals can produce functional B cells, they cannot synthesize secretory IgM (μS-/-) or perform Ig class switching (AID-/-), leading to complete antibody deficiency. Agammaglobulinemia did not affect overall post-MI survival but resulted in a significant reduction in infarct size. Echocardiographic analyses showed that, compared with wild-type infarcted control mice, AID-/-μS-/- mice exhibited improved cardiac function and reduced remodeling on day 56 post-MI. These differences remained significant even after animals with matched infarct sizes were compared. Infarcted AID-/-μS-/- mice also showed reduced myocardial expression levels of transcripts known to promote adverse remodeling, such as matrix metalloproteinase-9, collagen type I a1, collagen type III a1, and IL-6. An unbiased screening of the heart reactivity potential in the plasma of wild-type MI animals revealed the presence of antibodies that target the myocardial scar and collagenase-sensitive epitopes. Moreover, we found that IgG accumulated within the scar tissues of infarcted mice and remained in close proximity with cells expressing Fcγ receptors (CD16/32), suggesting the existence of an in situ IgG-Fcγ receptor axis. Collectively, our study results confirm that antibodies contribute to ischemic heart failure progression and provide novel insights into the mechanisms underlying this phenomenon. NEW & NOTEWORTHY Our study sheds some light on the long-standing debate over the relevance of autoantibodies in heart failure and might stimulate future research in the field. The observation of extracellular matrix-specific antibodies and the detection of Fcγ receptor-expressing cells within the scar provide novel insights into the mechanisms by which antibodies may contribute to adverse remodeling.

Keywords

Agammaglobulinemia Animals Autoantibodies Disease Models, Animal Extracellular Matrix Fibrosis Heart Failure Immunoglobulin M Male Mice, Inbred C57BL Mice, Transgenic Myocardial Infarction Myocarditis Myocardium Receptors, IgG Ventricular Function, Left Ventricular Remodeling Immunoglobulin Class Switching